PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29517210
OWN - NLM
STAT- MEDLINE
DCOM- 20180312
LR  - 20180313
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 378
IP  - 10
DP  - 2018 Mar 8
TI  - Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
PG  - 966
LID - 10.1056/NEJMc1800394 [doi]
FAU - Gogtay, Nithya J
AU  - Gogtay NJ
AD  - King Edward Memorial Hospital, Mumbai, India
FAU - Bose, Debdipta
AU  - Bose D
AD  - King Edward Memorial Hospital, Mumbai, India
AD  - [email protected]
FAU - Thatte, Urmila M
AU  - Thatte UM
AD  - King Edward Memorial Hospital, Mumbai, India
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Insulin)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Dec 14;377(24):2337-2348. PMID: 28899222
CIN - N Engl J Med. 2018 Mar 8;378(10 ):966-968. PMID: 29514037
MH  - Blood Glucose
MH  - *Diabetes Mellitus, Type 1
MH  - Drug Therapy, Combination
MH  - Glycated Hemoglobin A/analysis
MH  - Humans
MH  - Hypoglycemic Agents
MH  - *Insulin
MH  - Treatment Outcome
EDAT- 2018/03/09 06:00
MHDA- 2018/03/13 06:00
CRDT- 2018/03/09 06:00
PHST- 2018/03/09 06:00 [entrez]
PHST- 2018/03/09 06:00 [pubmed]
PHST- 2018/03/13 06:00 [medline]
AID - 10.1056/NEJMc1800394 [doi]
AID - 10.1056/NEJMc1800394#SA1 [pii]
PST - ppublish
SO  - N Engl J Med. 2018 Mar 8;378(10):966. doi: 10.1056/NEJMc1800394.